Expressive Writing for Racism
(WW Trial)
Trial Summary
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It seems unlikely that you would need to stop, as the trial focuses on expressive writing rather than medication.
What data supports the idea that Expressive Writing for Racism is an effective treatment?
The available research does not provide specific data supporting the effectiveness of Expressive Writing for Racism as a treatment. Instead, it focuses on the impact of microaggressions and the need for better responses and support for those affected. There is a call for more research on interventions to help those suffering from microaggressions, but no specific evidence is presented for Expressive Writing for Racism.12345
What safety data exists for Expressive Writing for Racism?
The provided research does not directly address safety data for Expressive Writing for Racism or similar treatments like Writing Wrongs or Expressive Writing for Microaggressions. The studies focus on adverse event reporting in healthcare settings, highlighting disparities in reporting by race, gender, and other factors. However, they do not provide specific safety data for the expressive writing interventions mentioned.678910
Is the treatment 'Writing Wrongs' a promising treatment for dealing with racism?
Yes, 'Writing Wrongs' is a promising treatment because it helps people express their feelings about racial microaggressions, which are everyday insults or slights that can harm people of color. By writing about these experiences, individuals can process their emotions and potentially reduce the negative impact of these microaggressions on their mental health.1112131415
What is the purpose of this trial?
Racial and ethnic based stressors, such as microaggressions, are pervasive, distressing, and result in lasting negative repercussions for minoritized students at predominantly white institutions (PWIs). These racial and ethnic based stressors are experienced in addition to the universally experienced stressors of higher education. Negative repercussions of microaggressions include increased drop out or transfer rates, distress, fatigue resulting in decreased academic performance, and depression and posttraumatic stress symptoms. Expressive writing (EW) may be a scalable intervention for addressing the negative repercussions resulting from microaggressions experienced by minoritized students at PWIs. Previous research suggests that EW for stressful life events results in benefits such as reduced depression and posttraumatic stress symptoms, improved coping strategies, and reduced activity restriction. Despite such benefits, EW was not designed to specifically address microaggressions in a minoritized student population. Informed by the ADAPT-ITT model, our research group conducted a pilot study with similar procedures. This pilot study demonstrated the acceptability of an adapted version of the EW intervention titled Writing Wrongs (WW), as well as recommended future modifications for WW. In the current study we aim to conduct a randomized-controlled trial to establish the efficacy of WW in alleviating clinical symptoms. We hypothesize that WW will improve symptoms of racial and discriminatory trauma and symptoms of depression, anxiety, and posttraumatic stress over time and compared to an assessment-only condition. We will conduct exploratory analyses to examine short-term changes in affect within and across sessions and across conditions. We will recruit minoritized students enrolled at a PWI. Participants will complete a pre-intervention assessment prior to being randomized into the two conditions. Participants in the intervention condition will engage in three sessions of WW and complete measures of clinical symptoms across multiple time points (i.e., pre-intervention, immediately after the final writing session, one week after the final session). Participants in the assessment-only condition will be administered the same measures at the same timepoints and given access to the WW after completing the study. If found to be efficacious, WW has the potential to be widely disseminated to minoritized college students who experience microaggressions.
Research Team
Tracy K Witte, PhD
Principal Investigator
Auburn University Department of Psychological Sciences
Eligibility Criteria
This trial is for full-time students at Auburn University who identify with a racial or ethnic minoritized group and are over the age of 18. It aims to help those experiencing stress from microaggressions, which can lead to negative effects like poor academic performance and mental health issues.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-intervention Assessment
Participants complete a pre-intervention assessment to establish baseline measures
Treatment
Participants in the Writing Wrongs condition engage in three 20-minute writing sessions on consecutive days
Post-intervention Assessment
Participants complete a post-intervention assessment immediately after the final writing session
Follow-up
Participants are monitored for changes in symptoms one week after the intervention
Treatment Details
Interventions
- Writing Wrongs
Find a Clinic Near You
Who Is Running the Clinical Trial?
Auburn University
Lead Sponsor
Medical University of South Carolina
Collaborator